Background
==========

Primary cardiac tumors represent a rare neoplastic condition with an incidence that ranges from 0.0017 to 0.019% \[[@B1]\], of which 25% are malignant. Among such tumors, angiosarcoma is the commonest malignant tumor followed by rhabdomyosarcoma, malignant mesothelioma, and fibrosarcoma, each with an incidence that is greater than 10% \[[@B2]\]. However, the incidence of cardiac leiomyosarcoma is less than 1% \[[@B2]\]. Previous studies of leiomyosarcoma with rhabdomyoblastic differentiation have conducted to those arisen from another site \[[@B3]-[@B11]\], and they announced a poorer prognosis of this tumor. Especially, Oshiro et al. have reported that leiomyosarcoma with rhabdomyoblastic differentiation shows poorer prognosis than typical leiomyosarcoma \[[@B6]\]. In the present paper, we describe an extremely rare primary cardiac malignant tumor. To the best of our knowledge, this is the first case of primary cardiac leiomyosarcoma with partial rhabdomyoblastic differentiation.

Case presentation
-----------------

A 69-year-old woman was referred to our hospital for an operation concerning umbilical hernia who had been diagnosed with hypertension and polycystic kidney disease one year prior to her surgery. Subsequent transthoracic cardiac ultrasonography in our hospital showed a club-shaped tumor of 34 mm in diameter inside the left atrial cavity in a four-cavities tomogram. Transesophageal cardiac ultrasonography showed a broad-based, gigantic, and multilocular tumor occupying almost the entire left atrium (Figure [1](#F1){ref-type="fig"}). Chest computed tomography (CT) showed no abnormality in the lungs or hilar lymph nodes. Abdominal CT showed multilocular cysts in bilateral kidneys. Cardiac magnetic resonance imaging showed a broad-based protuberant tumor which had a T1 iso-signal intensity and high T2 signal intensity in the posterior wall of the left atrium. Positron emission tomography analysis showed abnormal 18F- fluorodeoxy glucose uptake which was detected only in the heart, with the exception of the umbilical hernia lesion. These results indicated the presence of primary cardiac malignant tumor due to its atypical shape. Finally, surgical removal with the patient\'s permission was performed. Almost all of the tumor could be removed and subsequent chemotherapy was considered. However, the patient\'s renal dysfunction ruined adjuvant chemotherapy and she died of her disease nine months after the surgical removal due to multiple lung metastases.

![**Photograph showing cardiac ultrasonography**. (A) Transthoracic cardiac ultrasonography performed in our hospital showed showing a club -shaped tumor of 34 mm in diameter inside the left atrial cavity in a four-cavities tomogram. (B) Transesophageal cardiac ultrasonography showed showing a broad-based, gigantic, and multilocular tumor occupying almost the entire left atrium.](1471-2407-11-76-1){#F1}

Pathologic findings
-------------------

Macroscopically, the submitted specimen comprised several cakes of the tumor with a gray-white color on the surface (Figure [2](#F2){ref-type="fig"}). It was fixed with 10% buffered formalin, embedded in paraffin wax after dehydration, and cut into four μm-thick sections. These were then prepared and stained with hematoxylin and eosin (HE) double stain for light microscopic observation.

![**Photograph of the surgical specimen**. The submitted specimen comprised several cakes of the tumor (measuring up to 41 × 28 × 14 mm in size) with a gray-white color on the surface.](1471-2407-11-76-2){#F2}

Histopathologically, tumor cells that had proliferated in the myxoedematous matrix (Figure [3A](#F3){ref-type="fig"}) consisted of two different types: a large portion comprised spindle cells, and polyhedral cells were also identified as a minor component. Spindle cells had an elongated, blunt-ended and hyperchromatic nucleus plus spindle, were fibrillated and possessed an eosinophilic cytoplasm (Figure [3D](#F3){ref-type="fig"} and [4A](#F4){ref-type="fig"}). In contrast, polyhedral cells had a hyperchromatic and eccentric nucleus with a polyhedral, large, and eosinophilic cytoplasm (Figure [5A](#F5){ref-type="fig"}). Spindle cells showed twelve mitoses per ten high-power fields. Accordingly, the histological grade of the tumor corresponded to grade-2 (tumor differentiation: score-2; mitotic counts: score-2; tumor necrosis: score-1) following to the French National Federation of Cancer Centers (FNCLCC) grading system (Figure [3C](#F3){ref-type="fig"} and [3D](#F3){ref-type="fig"}) \[[@B12]\].

![**Photomicrographs showing spindle cells with areas of hypercellularity or necrosis**. (A) Low-power view of the area with spindle cells proliferation (Hematoxylin and Eosin (HE) double stain, × 40). (B) Spindle cells with positive reactivity for α-smooth muscle actin (SMA) comprise approximately 30% area of the tumor (Immunostain, anti-α-SMA × 40). (C) There is focus of necrosis in the limited the tumor. Following to the French National Federation of Cancer grading system, presence of tumor necrosis less than half in area corresponds to score-1 (HE double stain, × 100). (D) Spindle cells showed mitosis. On average, twelve mitoses per ten high-power fields were confirmed. Following to the French National Federation of Cancer grading system, mitotic activity of the present case corresponds to score-2 (HE double stain, × 1000).](1471-2407-11-76-3){#F3}

![**Photomicrographs showing spindle cells and their phenotypical expression**. (A) Spindle cells had an elongated, blunt-ended and hyperchromatic nucleus plus spindle, were fibrillated, and possessed an eosinophilic cytoplasm. Occasional cells have perinuclear vacuoles (Hematoxylin and Eosin double stain, × 400). (B, C, D, E, and F) Photomicrographs of immunostain with desmin (B), α-smooth muscle actin (C), myoglobin (D), myogenin (E), and cytokeratin CAM 5.2 (F), respectively (× 400).](1471-2407-11-76-4){#F4}

![**Photomicrographs showing polyhedral cells and their phenotypical expression**. (A) Polyhedral cells had a hyperchromatic and eccentric nucleus with a polyhedral, large, and eosinophilic cytoplasm (Hematoxylin and Eosin double stain, × 1000). (B, C, D, E, and F) Photomicrographs of immunostain with desmin (B), α-smooth muscle actin (C), myoglobin (D), myogenin (E), and cytokeratin CAM 5.2 (F), respectively (× 1,000).](1471-2407-11-76-5){#F5}

Although a few polyhedral cells were confirmed, morphological findings on HE double stain indicated a myxoid type of leiomyosarcoma.

Immunohistochemical findings
----------------------------

Several kinds of monoclonal antibody were used to evaluate tumor cells immunohistochemically and included anti-Vimentin, CD31, CD34, cytokeratin (CK AE1/AE3, 34 β-E 12, 5/6, and CAM 5.2), desmin, α-smooth muscle actin (α-SMA), myoglobin, myogenin, and Ki-67 (MIB-1) antibodies. All tumor cells showed strong positive reactivity for vimentin and negative reactivity for CD31, CD34, and myoglobin (Figure [4D](#F4){ref-type="fig"} and [5D](#F5){ref-type="fig"}). Spindle cells showed focal positive reactivity for desmin, α-SMA, and cytokeratin CAM 5.2 (Figure [4B, C](#F4){ref-type="fig"}, and [4F](#F4){ref-type="fig"}). In contrast, polyhedral cells showed positive reactivity for desmin, but negative reactivity for α-SMA and cytokeratin CAM 5.2 (Figure [5B, C](#F5){ref-type="fig"}, and [5F](#F5){ref-type="fig"}). Ki-67 (MIB-1) labeling index in the spindle and polyhedral cells were estimated as 27.1% and 33.3%, respectively. It is interesting to note that 2.1% of spindle cells and 23.1% of polyhedral cells showed positive reactivity for myogenin (Figure [4E](#F4){ref-type="fig"} and [5E](#F5){ref-type="fig"}). Furthermore, to determine whether tumor cells are present as double positive for both α-SMA and myogenin, and to ascertain the morphological characteristics of these tumor cells, we performed double-immunostaining for α-SMA and myogenin. The rates of α-SMA and myogenin double negative, α-SMA single positive, myogenin single positive, and α-SMA and myogenin double positive in spindle cells were estimated as 69.1%, 28.8%, 1.1%, and 1.0%, respectively (Figure [6A, B, C](#F6){ref-type="fig"}, and [6D](#F6){ref-type="fig"}). In contrast, the rates in polyhedral cells were estimated as 76.9%, 0.0%, 23.1%, and 0.0%, respectively. These results are summarized in Table [1](#T1){ref-type="table"}. According to the morphological and immunohistochemical findings, we diagnosed this primary cardiac tumor as a leiomyosarcoma with partial rhabdomyoblastic differentiation.

![**Photomicrograph showing the results of double-immunostaining of spindle cells**. Positive reactivity for α-smooth muscle actin (SMA) is recognized as a blue immunohistochemical signal in the cytoplasm, and for myogenin is recognized as a red immunohistochemical signal in the nucleus. (A) Negative reactivity for both α-SMA and myogenin (× 1000). (B) Positive reactivity for α-SMA alone (× 1000). (C) Positive reactivity for myogenin alone (× 1000). (D) Positive reactivity for both α-SMA and myogenin (× 1000).](1471-2407-11-76-6){#F6}

###### 

Summary of phenotypical expression by immunohistochemical examination

  ----------------------------------------------------------------------
                                        Spindle cell   Polyhedral cell
  ------------------------------------- -------------- -----------------
  α-SMA and myogenin double negative\   69.1%          76.9%
  α-SMA (-) and myogenin (-)                           

  α-SMA single positive\                28.8%          0.0%
  α-SMA (+) and myogenin (-)                           

  myogenin single positive\             1.1%           23.1%
  α-SMA (-) and myogenin (+)                           

  α-SMA and myogenin double positive\   1.0%           0.0%
  α-SMA (+) and myogenin (+)                           
  ----------------------------------------------------------------------

SMA: smooth muscle actin

The rates of α-SMA and myogenin double negative, α-SMA single positive, myogenin single positive, and α-SMA and myogenin double positive in spindle cells were estimated as 69.1%, 28.8%, 1.1% and 1.0%, respectively.

Discussion
==========

Leiomyosarcoma occurring as a primary cardiac tumor has been known as an extremely rare condition of which the rate represents less than 1% of all primary cardiac malignant tumors \[[@B2]\]. Furthermore, to the best of our knowledge there has been no report of a case of primary cardiac leiomyosarcoma with partial rhabdomyoblastic differentiation. In general, leiomyosarcoma is currently subdivided histologically into four types: classical, epithelioid, pleomorphic, and myxoid \[[@B13]\]. The morphological findings of the present case indicated a myxoid type of leiomyosarcoma, but immunohistochemistry revealed that a few tumor cells showed positive reactivity for myogenin. This has been known as a myogenic transcriptional regulatory protein which is expressed in the early phase of skeletal muscle differentiation (rhabdomyogenic differentiation), and it induces differentiation of myoblasts into the multinucleated myotube \[[@B14]\]. This myogenic regulatory protein has been largely accepted as a sensitive and specific immunohistochemical marker for rhabdomyosarcoma or other tumors with rhabdomyoblastic differentiation \[[@B14]\].

Meanwhile, it is interesting to note that the spindle cell showed positive reactivity for CK CAM 5.2. Although, it has been well known that leiomyosarcoma usually showed negative reactivity for epithelial markers \[[@B15]\], some investigators described that a part of leiomyosarcoma shows positive reactivity for CK \[[@B15]-[@B17]\]. Therefore, CK CAM 5.2 expression in the present case may support a diagnosis of leiomyosarcoma. However, to make diagnosis of leiomyosarcoma with rhabdomyoblastic differentiation, we should refer three important tumors and deny them, respectively, which comprise undifferentiated pleomorphic sarcoma (UPS), rhabdomyosarcoma, and rhabdomyoma. Cardiac UPS usually occurring at the left atrium, histopathologically comprises a mixture of spindle cells in a storiform pattern with polyhedral cells \[[@B5]\]. Furthermore, high-grade undifferentiated sarcomas can exhibit focal α-SMA expression \[[@B15]\]. These findings are similar to the present case. However, the spindle cell, a major component of the present tumor, had an elongated, blunt-ended, and hyperchromatic nucleus plus spindle, fibrillated, and eosinophilic cytoplasm. In addition, the cell showed positive reactivity both for α-SMA and desmin, focally, by immunohistochemical examination. These findings allowed disclosing the smooth muscle differentiation. Furthermore, some of the spindle cell also showed positive reactivity for CK CAM 5.2, of which positive ratio has been reported ranging from 22.2% (2/9) to 35.0% (14/40) in leiomyosarcoma \[[@B16],[@B17]\]. Although it still remains a difficulty for decision, we made the diagnosis of leiomyosarcoma rather than UPS. On the other hand, since rhabdomyosarcoma has been know as the second most common primary cardiac malignant tumor \[[@B2]\], that should also be considered as a disease for differential diagnosis. Especially, embryonal rhabdomyosarcoma usually shows similar morphologic findings of the present case, such as varying degrees of cellularity containing hypercellular and loosely textured myxoid areas, hyperchromatic and round or spindle-shaped nucleus, and eosinophilic cytoplasm \[[@B18]\]. However, embryonal rhabdomyosarcoma is uncommon in patients older than 40 years of age \[[@B18]\] and neither cross-striation nor myoglobin expression was proven in the present case. Furthermore, a large body of spindle cells showed negative reactivity for myogenin (only 2.1% of them showed positive reactivity) that has been largely accepted as a sensitive and specific immunohistochemical marker for rhabdomyosarcoma or other tumors with rhabdomyoblastic differentiation \[[@B14]\]. According to our immunohistochemical examinations, we were able to deny typical rhabdomyosarcoma. As for rhabdomyoma, the most common subtype of cardiac origin has been known as cardiac rhabdomyoma, but it occurs almost exclusively in the hearts of infants and young children and composes predominantly large polygonal vacuolated spider cells \[[@B19]\]. Therefore, the adult type of rhabdomyoma should be considered as differential diagnosis which is usually composed of tightly polygonal cells which had peripherally placed nucleus plus acidophilic, finely granular, and vacuolated cytoplasm. However, mitotic figures are nearly absent, cross-striations can be discerned, and show positive reactivity for rhabdomyogenic markers immunohistochemically in these two subtypes of rhabdomyoma \[[@B19]\]. These results were different from the findings extracted from the present case.

On the other hand, only one case of sarcoma arisen from myocardium with rhabdomyoblastic differentiation has been reported by Kabir et al. \[[@B20]\] who described a malignant peripheral nerve sheath tumor indicated an area of rhabdomyoblastic differentiation in part. In their report, a little information of immunohistochemical examinations was described which simply comprised positive reactivity for s-100 protein and focal for desmin. These results were different from these of the present case, but comparative discussion could not be completed in detail. Therefore, we preferred to diagnose this primary cardiac malignant tumor as a leiomyosarcoma with partial rhabdomyoblastic differentiation. Previous studies of leiomyosarcoma with rhabdomyoblastic differentiation have conducted to those arisen from another site, and Oshiro et al. have reported that leiomyosarcoma with rhabdomyoblastic differentiation shows poorer prognosis than typical leiomyosarcoma \[[@B6]\]. In fact, the present case showed rapid growth of the tumor and the patient died due to extensive metastases in the lungs despite early diagnosis and surgical removal. Table [2](#T2){ref-type="table"} presented herein summarizes major clinical data of nineteen cases of leiomyosarcoma in soft tissue with rhabdomyoblastic differentiation, and includes the present case representing the first report of leiomyosarcoma arising from the myocardium \[table [2](#T2){ref-type="table"}\]. The patient age ranged from 33 to 85 (mean: 62.7). The male-to-female ratio was 10:10. The tumor sizes ranged from 20 to 250 mm (mean: 116.4).

###### 

Literature summary of cases of leiomyosarcoma with rhabdomyoblastic differentiation

  Reference                     Year   Age (years)   Sex      Site                 Size (mm)   Operation and adjuvant therapy                             Follow up
  ----------------------------- ------ ------------- -------- -------------------- ----------- ---------------------------------------------------------- -------------------------------------------------------------
  Falconieri et al \[[@B3]\].   1996   83            Female   Breast               60          Radical mastectomy                                         10 mo NED
  Roncaroli et al \[[@B4]\].    1996   59            Female   Retroperitoneum      170         Excision                                                   8 mo NED
  Leoong et al \[[@B5]\].       1996   56            Male     Stomach              60          Partial gastrectomy                                        NR
  Oshiro et al \[[@B6]\].       2000   55            Female   Abdominal cavity     180         Marginal excision                                          85 mo NED
  Oshiro et al \[[@B6]\].       2000   62            Female   Omentum              130         Marginal excision                                          NR
  Oshiro et al \[[@B6]\].       2000   53            Female   Thigh, subcutis      80          Wide excision                                              19 mo DOD
  Oshiro et al \[[@B6]\].       2000   76            Male     Buttock, subcutis    60          Wide excision                                              27 mo NED
  Oshiro et al \[[@B6]\].       2000   33            Male     Thigh muscle         60          Wide excision                                              45 mo DOD
  Oshiro et al \[[@B6]\].       2000   54            Male     Thigh muscle         220         Wide excision and chemotherapy                             Lung metastasis, 9 mo DOD
  Oshiro et al \[[@B6]\].       2000   84            Male     Buttock              30          Wide excision, radiation, and chemotherapy                 93mo NED
  Oda et al \[[@B7]\].          2001   50            Female   Back                 NR          Excision                                                   6 mo DOD
  Oda et al \[[@B7]\].          2001   60            Male     Retroperitoneum      140         Excision                                                   NR
  Oda et al \[[@B7]\].          2001   85            Male     Buttock              20          Excision                                                   5 mo local recurrence (additional wide excision), 65 mo NED
  Oda et al \[[@B7]\].          2001   33            Male     Thigh                60          Wide excision and chemotherapy                             Lung metastasis, 45 mo DOD
  Oda et al \[[@B7]\].          2001   76            Male     Buttock              60          Excision                                                   NR
  Levine et al \[[@B8]\].       2002   72            Female   Uterus               210         Hysterectomy with salpingo-oophorectomy                    6 mo NED
  Shintaku et al \[[@B9]\].     2004   70            Female   Uterus               250         Hysterectomy with salpingo-oophorectomy and chemotherapy   Liver metastasis, outcome was NR
  Nikaido et al \[[@B10]\].     2004   67            Male     Inferior vena cava   140         Radical excision                                           Lung metastasis, 13 mo DOD
  Yorulmaz et al \[[@B11]\].    2007   56            Female   Uterus               240         Surgical removal, radiation, and chemotherapy              8 mo DOD
  Present case                  2009   69            Female   Heart                41          Surgical removal                                           Lung metastasis, 9 mo DOD

NR: not reported, DOD: died of disease, NED: no evidence of disease, mo: months

There are twenty cases of leiomyosarcoma with rhabdoid differentiation including the present case.

We wish to take a more detailed discussion on the present case, especially in relation to tumor cell differentiation with phenotypical expression analysis. The spindle cell, a major component of the tumor, has the potential to differentiate into a smooth muscle cell which can be phenotypically identified with positive reactivity for α-SMA. However, we found 2.1% of spindle cells showed positive reactivity for myogenin, and half of myogenin-positive spindle cells showed positive reactivity for α-SMA at the same time. In contrast, none of polyhedral cells showed positive reactivity for α-SMA, but they exhibited a significantly higher myogenin-positive rate than spindle cells. These findings support the following hypothesis. First, the \"rhabdomyoblastic differentiation\" observed in the present case may represent the early stage of rhabdomyogenic differentiation because tumor cells showed positive reactivity for myogenin which has been known as a maker of cells in the early phase of rhabdomyogenic differentiation, and exhibited neither cross-striation nor myoglobin expression. Second, polyhedral cells may be in a more advanced stage of rhabdomyogenic differentiation than spindle cells because polyhedral cells were morphologically similar to rhabdomyoblasts and showed a significantly higher myogenin-positive rate than spindle cells.

Finally, the possibility of transdifferentiation or synchronous smooth and skeletal muscle differentiation in leiomyosarcoma was suggested in the present case because synchronous expression of α-SMA and myogenin was confirmed in 1.0% of spindle cells. Overall, our immunohistochemical evaluation indicated that rhabdomyoblastic differentiation in leiomyosarcoma might be generated not only by de novo generation from mesenchymal cells.

Conclusion
==========

We describe an extremely rare case of primary cardiac leiomyosarcoma with partial rhabdomyoblastic differentiation. The tumor indicated aggressive growth and the patient died despite early diagnosis and surgical removal. Furthermore, our immunohistochemical evaluation suggested that rhabdomyoblastic differentiation in leiomyosarcoma might be generated not only by de novo generation from mesenchymal cells. To the best of our knowledge, this is the first report of primary cardiac leiomyosarcoma with partial rhabdomyoblastic differentiation.
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